CBIO financials

Crescent Biopharma (CBIO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

CBIO income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$10.84M–-$152.63M-$133.45M–
2024––-$40.04M-$37.88M-0.59
2023$10.00K–-$39.28M-$36.90M-0.58
2022$75.00K–-$47.40M-$46.69M-0.89
2021$1.16M–-$63.45M-$63.43M-1.23
2020$10.16M–-$51.51M-$51.03M-1.12